Biotech

All Articles

AstraZeneca spends CSPC $100M for preclinical heart problem medication

.AstraZeneca has actually settled CSPC Pharmaceutical Team $one hundred thousand for a preclinical h...

Zephyrm seeks Hong Kong IPO to money phase 3 tissue therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock market, filing (PDF) for an IPO to money ...

Frazier Lifestyle Sciences collects $630M for little, mid-cap biotechs

.Frazier Life Sciences has actually sourced a further $630 million for its own fund concentrated on ...

GigaGen gathers as much as $135M BARDA money to hammer botulism

.Antitoxin fan GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its tech to address b...

GPCR agency Septerna files for IPO on strength of preclinical data

.Septerna will discover just how a biotech without "any sort of relevant scientific records" fares i...

Kurma closes to begin with $154M payload for most significant biotech fund as yet

.International VC firm Kurma Partners has revealed its newest biotech fund, along with 140 million e...

Prothena ensures one exec while an additional leaves behind-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of substantial management hirings, firings a...

Editas profit Vertex Cas9 licensing civil liberties for $57M

.Versus the scenery of a Cas9 license war that declines to pass away, Editas Medicine is cashing in ...

Ultragenyx tweaks genetics treatment dosing to dial up efficacy

.A minority of individuals taking Ultragenyx Drug's Wilson ailment gene therapy UX701 have come off ...

Biopharma unemployment rate maintains in Q3: Fierce Biotech study

.As summertime heat turns to cool winds, hopes that this year will take extensive market comfort hav...